MedTrace Logo

Aquatic Plyometrics for Adolescents With Patellofemoral Pain Syndrome

NCT07679464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-07-01

No results posted yet for this study

Summary

This study was designed to assess the effect of a 12-week hydro-kinetic plyometric (HK-Plyo) training on pain, muscle strength, disability, and quality of life (QoL) in adolescents with patellofemoral pain syndrome (PFPS). Fifty-six adolescents with PFPS were randomly allocated to the HK-Plyo group (n = 28, received the plyometric-based hydro-kinetic therapy program, twice/week, over 12 weeks) or the control group (n = 28, received standard exercise program). Both groups were assessed for pain, muscle strength, disability, and QoL pre and post-treatment.

Conditions

  • Patellofemoral Pain Syndrome

Interventions

OTHER

Hydro-Kinetic Plyometric Exercise Program

Participants underwent a structured HK-Plyo program conducted in a water medium (pool). The intervention consisted of 24 total sessions, delivered twice a week for 12 consecutive weeks. Each 45-minute session included a 10-minute aquatic warm-up, a 30-minute core plyometric phase, and a 5-minute cool-down. The core phase consisted of 10 unilateral and bilateral lower-limb plyometric exercises, including variations of hopping, bounding, and jumping. Exercise prescription, progression, and safety parameters strictly adhered to the National Strength and Conditioning Association (NSCA) guidelines and the American Academy of Pediatrics (AAP) safety standards.

OTHER

Standard Exercise Program (Conventional Physical Therapy)

Participants underwent a standard, land-based exercise program. The intervention consisted of 24 total sessions, delivered twice a week for 12 consecutive weeks, with each session lasting 45 minutes. The program was multimodal and consisted of lower-limb flexibility exercises, progressive lower-extremity strength training, weight-bearing exercises, proprioceptive training, and balance exercises.

Sponsors & Collaborators

  • Prince Sattam Bin Abdulaziz University

    collaborator OTHER

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-04
Primary Completion
2024-05-30
Completion
2024-05-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07679464 on ClinicalTrials.gov